A consumer coalition dedicated to health care reform has filed lawsuits against eight major pharmaceutical companies, claiming their popular coupon programs for brand-name prescription drugs are illegal. The coalition is seeking class-action status in its commercial litigation on behalf of insurance plans that could make up more than 60 percent of the U.S. healthcare market.
The end of this month marks a milestone in the pharmaceutical industry's intellectual property. The patent for Lipitor, the top-selling drug in the world, will expire. This means generic versions of the drug will soon be available, making it significantly less expensive and more accessible.